ANI Pharmaceuticals to Discuss Second Quarter 2024 Financial Results on August 6, 2024, at 8:30 a.m. ET
ANI Pharmaceuticals (NASDAQ: ANIP) has announced its plans to release second quarter 2024 financial results on Tuesday, August 6, 2024, before the market opens. The company will host a conference call at 8:30 a.m. ET on the same day to discuss the results. Nikhil Lalwani, President and CEO, and Stephen P. Carey, SVP of Finance and CFO, will lead the call.
Investors and interested parties can access the call toll-free at 800-245-3047 using the Conference ID 4619279. A live webcast and replay will be available on the company's website under the 'Investors' section. For those unable to attend, a replay will be accessible for two weeks by dialing 800-753-5212 with the same access code.
ANI Pharmaceuticals (NASDAQ: ANIP) ha annunciato i suoi piani per pubblicare i risultati finanziari del secondo trimestre 2024 martedì 6 agosto 2024, prima dell'apertura del mercato. L'azienda ospiterà una conferenza telefonica alle 8:30 a.m. ET nello stesso giorno per discutere i risultati. Nikhil Lalwani, Presidente e CEO, e Stephen P. Carey, SVP di Finanza e CFO, guideranno la chiamata.
Gli investitori e gli interessati possono accedere alla chiamata gratuitamente al numero 800-245-3047 utilizzando il Codice Conferenza 4619279. Sarà disponibile una trasmissione web in diretta e la registrazione sul sito web dell'azienda nella sezione 'Investitori'. Per coloro che non possono partecipare, una registrazione sarà accessibile per due settimane componendo 800-753-5212 con lo stesso codice di accesso.
ANI Pharmaceuticals (NASDAQ: ANIP) ha anunciado sus planes de publicar los resultados financieros del segundo trimestre de 2024 el martes 6 de agosto de 2024, antes de la apertura del mercado. La compañía llevará a cabo una conferencia telefónica a las 8:30 a.m. ET el mismo día para discutir los resultados. Nikhil Lalwani, Presidente y CEO, y Stephen P. Carey, SVP de Finanzas y CFO, liderarán la llamada.
Los inversores y partes interesadas pueden acceder a la llamada de forma gratuita al 800-245-3047 utilizando la ID de Conferencia 4619279. Se dispondrá de una transmisión en vivo y de una grabación en el sitio web de la compañía en la sección de 'Inversores'. Para aquellos que no puedan asistir, una grabación estará disponible durante dos semanas marcando el 800-753-5212 con el mismo código de acceso.
ANI 제약회사 (NASDAQ: ANIP)는 2024년 2분기 재무 결과를 2024년 8월 6일 화요일, 시장 개장 전에 발표할 계획이라고 발표했습니다. 회사는 같은 날 오전 8시 30분 ET에 결과를 논의하기 위해 컨퍼런스 콜을 개최할 예정이며, Nikhil Lalwani 사장 겸 CEO와 Stephen P. Carey 재무 부사장 겸 CFO가 전화를 주도할 것입니다.
투자자 및 관심 있는 당사자는 800-245-3047로 무료로 전화를 걸 수 있으며, 컨퍼런스 ID는 4619279입니다. 회사 웹사이트 '투자자' 섹션에서 생중계 및 녹화된 내용을 확인할 수 있습니다. 참석할 수 없는 분들은 같은 접근 코드를 사용하여 800-753-5212로 전화하시면 2주간 녹화된 내용을 이용하실 수 있습니다.
ANI Pharmaceuticals (NASDAQ: ANIP) a annoncé ses projets de publier les résultats financiers du deuxième trimestre 2024 le mardi 6 août 2024, avant l'ouverture du marché. L'entreprise organisera une conférence téléphonique le même jour à 8h30 ET pour discuter des résultats. Nikhil Lalwani, Président et CEO, et Stephen P. Carey, SVP des Finances et CFO, dirigeront l'appel.
Les investisseurs et les parties intéressées peuvent accéder à l'appel gratuitement au 800-245-3047 en utilisant l'ID de conférence 4619279. Un webinaire en direct ainsi qu'un replay seront disponibles sur le site Web de l'entreprise dans la section 'Investisseurs'. Pour ceux qui ne peuvent pas participer, un replay sera accessible pendant deux semaines en composant le 800-753-5212 avec le même code d'accès.
ANI Pharmaceuticals (NASDAQ: ANIP) hat bekannt gegeben, dass die Finanzergebnisse für das zweite Quartal 2024 am Dienstag, den 6. August 2024, vor Markteröffnung veröffentlicht werden. Das Unternehmen wird am selben Tag um 8:30 Uhr ET eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen. Nikhil Lalwani, Präsident und CEO, sowie Stephen P. Carey, SVP für Finanzen und CFO, werden das Gespräch leiten.
Investoren und Interessierte können die Konferenzgebührenfrei unter 800-245-3047 über die Konferenz-ID 4619279 erreichen. Eine Live-Webcast-Übertragung sowie eine Wiederholung werden im Bereich 'Investoren' auf der Unternehmenswebsite verfügbar sein. Für diejenigen, die nicht teilnehmen können, ist eine Wiederholung zwei Wochen lang unter der Telefonnummer 800-753-5212 mit dem gleichen Zugangscode verfügbar.
- None.
- None.
PRINCETON, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its second quarter 2024 financial results on Tuesday, August 6, 2024, prior to the market open.
Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, will host a conference call to discuss the results as follows:
| Date | Tuesday, August 6, 2024 |
| Time | 8:30 a.m. ET |
| Toll free (U.S.) | 800-245-3047 |
| Conference ID | 4619279 |
| Webcast (live and replay) | www.anipharmaceuticals.com, under the “Investors” section |
A replay of the conference call will be available within two hours of the call’s completion and will remain accessible for two weeks by dialing 800-753-5212 and entering access code 4619279.
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high-quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. The Company is focused on delivering sustainable growth by scaling up its Rare Disease business through its lead asset Purified Cortrophin® Gel, strengthening its Generics business with enhanced research and development capabilities, delivering innovation in Established Brands, and leveraging its U.S. based manufacturing footprint. For more information, visit www.anipharmaceuticals.com.
Investor Relations Contact:
Lisa M. Wilson, In-Site Communications, Inc.
212-452-2793
lwilson@insitecony.com
SOURCE: ANI Pharmaceuticals, Inc.
FAQ
When will ANI Pharmaceuticals (ANIP) release its Q2 2024 financial results?
What time is ANI Pharmaceuticals' (ANIP) Q2 2024 earnings call scheduled for?
How can investors access ANI Pharmaceuticals' (ANIP) Q2 2024 earnings call?
Who will be hosting ANI Pharmaceuticals' (ANIP) Q2 2024 earnings call?
